Computational Analysis Reveals Distinctive Interaction of miRNAs with Target Genes in the Pathogenesis of Chronic

Hafiz Muhammad Umar Salim1, Abdullahi Dandare1,2, Fareeha Khalil3

  • 1Department of Biosciences, COMSATS University Islamabad, Islamabad 45550, Pakistan.

Genes
|April 28, 2023
PubMed

Insights

MicroRNAs (miRNAs) show promise as early diagnostic biomarkers for chronic kidney disease (CKD). Specific miRNAs like hsa-miR-1-3p, hsa-miR-206, hsa-miR-494, and hsa-miR-577 are linked to CKD pathogenesis.

Area of Science:

  • Molecular Biology
  • Genetics
  • Biomarker Discovery

Background:

  • Gene expression regulation is vital for cellular health; dysregulation contributes to diseases like chronic kidney disease (CKD).
  • MicroRNAs (miRNAs) are implicated in kidney disease, but their role as diagnostic and therapeutic biomarkers for CKD remains unclear.
  • Early detection and treatment of CKD are critical for patient outcomes.

Purpose of the Study:

  • To investigate the potential of specific miRNAs as early diagnostic and therapeutic biomarkers for chronic kidney disease (CKD).
  • To identify key miRNAs and their target genes involved in the molecular pathways of CKD.

Main Methods:

  • Acquired gene expression profiling data from the Gene Expression Omnibus (GEO) to identify differentially expressed genes (DEGs).
  • Conducted an extensive literature search to identify miRNAs associated with CKD.
  • Performed network analysis of miRNAs and their target genes (tDEGs), followed by functional enrichment analysis using an in silico approach.

Main Results:

  • Identified four miRNAs (hsa-miR-1-3p, hsa-miR-206, hsa-miR-494, and hsa-miR-577) strongly associated with CKD.
  • These miRNAs regulate genes involved in crucial cellular processes including signal transduction, cell proliferation, transcription regulation, and apoptosis.
  • Demonstrated the significant contribution of these miRNAs to inflammatory responses and CKD pathogenesis.

Conclusions:

  • The identified miRNAs and their target genes represent potential molecular markers for CKD processes.
  • The study supports the development of a miRNA biomarker set for the early diagnosis of CKD.
  • Further research is recommended to validate these findings and translate them into clinical applications.

Related Concept Videos

Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
49
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
57
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.1K
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
37
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
47
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
32